product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
eIF4B Antibody
catalog :
NB100-93308
quantity :
0.1 ml
price :
459 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
more info or order :
citations: 1
product information
brand :
Novus
master code :
NB100-93308
SKU :
NB100-93308
product name :
eIF4B Antibody
unit size :
0.1 ml
seo description :
The eIF4B Antibody from Novus is a rabbit polyclonal antibody to eIF4B. This antibody reacts with human. The eIF4B Antibody has been validated for the following applications: Western Blot,Immunoprecipitation.
target :
eIF4B
category :
Primary Antibodies
buffer :
TBS and 0.1% BSA
clonality :
Polyclonal
concentration :
0.2 mg/ml
conjugate :
Unconjugated
dilution :
Western Blot 1:2000-1:10000, Immunoprecipitation 2-5 ug/mg lysate
host :
Rabbit
immunogen :
The immunogen recognized by this antibody maps to a region between residue 561 and 611 of human eukaryotic translation initiation factor 4B using the numbering given in entry NP_001408.2 (GeneID 1975).
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human
gene symbol :
EIF4B
Antibody validation :
Independent Antibodies
accessionNumbers :
P23588
applications :
Immunoprecipitation,Western Blot
USD :
459 USD
alt names :
EIF-4B, eukaryotic translation initiation factor 4B, PRO1843
storage :
Store at 4C. Do not freeze.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
related products
browse more products
questions and comments